KURE

Fund Description
KURE seeks to measure the performance of MSCI China All Shares Health Care 10/40 Index. The Index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the health care sector. The securities in the Index include all types of publicly issued shares of Chinese issuers, which are listed in Mainland China, Hong Kong and United States. Issuers eligible for inclusion must be classified under the Global Industry Classification Standard as engaged in the healthcare sector. The issuers included in the Underlying Index may include small-cap, mid-cap and large-cap companies.
Fund Profile
Fund Name Kraneshares MSCI All China Healthcare Index ETF
Fund Exchange Ticker KURE
Fund Sponsor Krane Shares
Fund ISIN US5007678353
Net Expense Ratio 0.82 %
Fund Inception Date 1 February 2018
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name MSCI China All Shares Health Care 10/40 Index
Index Provider MSCI
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Emerging Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Asia
Key Statistics
Return As of Date 17 July 2019
Asset Under Management 18.68 Million (USD)
1 Month Total Return 8.35 %
Year To Date Return 19.65 %
1 Year Total Return -24.20 %
3 Year Annualized Total Return
NAV 20.75
Share Outstanding 900,002
Top 10 Holdings (17 July 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
JIANGSU YUYUE-A 002223 EQUI
TRAD CHI MED 570 EQUI
BEIJING TIAN-A 600161 EQUI
JAFRON BIOMEDI-A 300529 EQUI
CHINA RESOURCE-A 000999 EQUI
SHENZHEN KANGT-A 300601 EQUI
JIANGSU HENGRU-A 600276 EQUI
FOSUN PHARMA-H 2196 EQUI
HANGZHOU TIGER-A 300347 EQUI
SHANGHAI PHARM-H 2607 EQUI